- Home
- IMA vs IXHL Comparison
IMA vs IXHL Comparison
Compare IMA & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMA
- IXHL
- Stock Information
- Founded
- IMA 2019
- IXHL 2001
- Country
- IMA United States
- IXHL Australia
- Employees
- IMA N/A
- IXHL N/A
- Industry
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- IXHL
- Sector
- IMA Health Care
- IXHL
- Exchange
- IMA Nasdaq
- IXHL Nasdaq
- Market Cap
- IMA 69.5M
- IXHL 78.7M
- IPO Year
- IMA N/A
- IXHL N/A
- Fundamental
- Price
- IMA N/A
- IXHL $0.39
- Analyst Decision
- IMA
- IXHL
- Analyst Count
- IMA 0
- IXHL 0
- Target Price
- IMA N/A
- IXHL N/A
- AVG Volume (30 Days)
- IMA 45.7K
- IXHL 218.8M
- Earning Date
- IMA 01-01-0001
- IXHL 09-29-2025
- Dividend Yield
- IMA N/A
- IXHL N/A
- EPS Growth
- IMA N/A
- IXHL N/A
- EPS
- IMA N/A
- IXHL N/A
- Revenue
- IMA N/A
- IXHL $98,000.00
- Revenue This Year
- IMA N/A
- IXHL $2,538.49
- Revenue Next Year
- IMA N/A
- IXHL $249.95
- P/E Ratio
- IMA N/A
- IXHL N/A
- Revenue Growth
- IMA N/A
- IXHL N/A
- 52 Week Low
- IMA $11.65
- IXHL $0.08
- 52 Week High
- IMA $23.28
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- IMA N/A
- IXHL 44.26
- Support Level
- IMA N/A
- IXHL $0.95
- Resistance Level
- IMA N/A
- IXHL $1.32
- Average True Range (ATR)
- IMA 0.00
- IXHL 0.24
- MACD
- IMA 0.00
- IXHL -0.03
- Stochastic Oscillator
- IMA 0.00
- IXHL 9.93
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.